Biomaterial Database

Vitamin E therapy in abetalipoproteinaemia. 1970

D R Muller, and J T Harries, and J K Lloyd

UI	MeSH Term	Description	Entries
D002648	Child	A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.	Children
D002675	Child, Preschool	A child between the ages of 2 and 5.	Children, Preschool,Preschool Child,Preschool Children
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000012	Abetalipoproteinemia	An autosomal recessive disorder of lipid metabolism. It is caused by mutation of the microsomal triglyceride transfer protein that catalyzes the transport of lipids (TRIGLYCERIDES; CHOLESTEROL ESTERS; PHOSPHOLIPIDS) and is required in the secretion of BETA-LIPOPROTEINS (low density lipoproteins or LDL). Features include defective intestinal lipid absorption, very low serum cholesterol level, and near absent LDL.	Bassen-Kornzweig Syndrome,Microsomal Triglyceride Transfer Protein Deficiency,Acanthocytosis,Bassen-Kornzweig Disease,Betalipoprotein Deficiency Disease,Microsomal Triglyceride Transfer Protein Deficiency Disease,Acanthocytoses,Bassen Kornzweig Disease,Bassen Kornzweig Syndrome,Betalipoprotein Deficiency Diseases,Deficiency Disease, Betalipoprotein,Deficiency Diseases, Betalipoprotein,Disease, Betalipoprotein Deficiency,Diseases, Betalipoprotein Deficiency
D000284	Administration, Oral	The giving of drugs, chemicals, or other substances by mouth.	Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D014810	Vitamin E	A generic descriptor for all TOCOPHEROLS and TOCOTRIENOLS that exhibit ALPHA-TOCOPHEROL activity. By virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of antioxidant activity, depending on the site and number of methyl groups and the type of ISOPRENOIDS.